Pharmaceutical Potential of Marine Microorganisms
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 December 2022) | Viewed by 12749
Special Issue Editors
Interests: natural products; marine drugs; cytotoxicity, antiviral agents; nonribosomal peptides; structure and activity; cyanobacteria toxins; peptidomics
Special Issues, Collections and Topics in MDPI journals
Interests: marine microbes; bioactive natural products; marine drugs; nonribosomal peptides; antibacterial activity; molecular ecology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine microorganisms and their products have found application in many areas life. Extensive exploration into marine microorganisms started in the 21st century, and only a fraction of their real potential has been discovered.
As a follow-up to the previous Special Issue on Bioactive Molecules from Marine Microorganisms, which was edited as a Special Issue Book, we decided to announce a second version of the issue focusing on Pharmaceutical Potential of Marine Microorganisms. This time, we aim to provide a platform for researchers to publish their latest findings on microbial metabolites that have potential to be developed into drugs. You are invited to contribute to this Special Issue with submissions on the discovery of bioactive products, and identification and characterization of source organisms, including free-living and symbiotic marine microorganisms. We also encourage submissions related to biosynthesis, structure–activity studies, drug-like properties of microbial products, leads optimization and alternative methods of production.
Comprehensive review articles that synthesize the current knowledge on the pharmaceutical potential of bioactive products from marine microbes are also welcome.
Prof. Dr. Hanna Mazur-Marzec
Dr. Anna Toruńska-Sitarz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Marine microorganisms
- Natural products
- Bioactivity
- Anticancer
- Antibacterial
- Antifungal
- Antiviral
- Immunomodulating activity
- Enzyme inhibitors
- Biosynthesis
- Genome mining
- Structure elucidation
- Bioprospecting